CCRB Logo

Trial History Detail on 2009-11-19

CUHK_CCT00016

2005-09-05

Retrospective

Chinese University of Hong Kong Institute of Chinese Medicine; Chinese University of Hong Kong; and BUPA Foundation

The Chinese University of Hong Kong

Kwong Wah Hospital

Fion Yip

Tel or Tel [852] 26323593

email or Email fionyip@cuhk.edu.hk

Larry Baum

Tel or Tel [852] 26323146

email or Email lwbaum@cuhk.edu.hk

A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease

Curcumin for AD

Yes

2003-04-23

Nervous System Diseases

Drug

Curcumin and ginkgo extract

6 months

Placebo

Inclusion: Possible or probable AD.

Exclusion: Anticoagulant or antiplatelet treatment or bleeding risk factors; currently smoking; or other severe illness.

Randomized

Placebo

Double-blind

Parallel

2004-10-07

30

Recruiting

Setting up formulation, patient recruitment, and assay procedures at 0, 1, and 6 months, in preparation for a later clinical trial testing the effectiveness of curcumin and ginkgo in slowing AD progression.

Change in biochemical measures of AD: Plasma isoprostane and A-beta levels at 1 and 6 months. Change in cognitive measures of AD: MMSE at 6 months. Change in others: cholesterol, lipid, C reactive protein, and metal levels in serum at 1 and 6 months. Curcumin and metabolites at 1 month.

No

2011-03-02


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.